| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |